PDSB — PDS Biotechnology Share News
0.000.00%
Last trade - 00:00PDS Biotechnology Q3 net loss narrows on lower R&D costs
PDS Biotechnology Corp expected to post a loss of 10 cents a share - Earnings Preview
Brief: PDS Biotech Announces Initial Closing Of Up To $22.3 Mln PIPE Financing
Brief: Pds Biotechnology Corp - On Aug 6, Approved Reduction In Force To Align Expenses With Strategic Priorities - SEC Filing
Brief: PDS Biotechnology Says Lars Boesgaard To Resign As CFO Effective September 12
PDS Biotechnology Corp reports results for the quarter ended June 30 - Earnings Summary
PDS Biotechnology Q2 net loss widens slightly as operating costs fall
Brief: PDS Biotechnology Q2 EPS USD -0.18
PDS Biotechnology Corp expected to post a loss of 13 cents a share - Earnings Preview
PDS Biotechnology Q1 net loss narrows
Brief: PDS Biotechnology Q1 EPS USD -0.13
U.S. STOCKS ON THE MOVE-Nike, PNC Financia, OSI Systems
U.S. STOCKS ON THE MOVE-Nike, PNC Financial, Papa John's
U.S. STOCKS ON THE MOVE-Gitlab, Snap, Robinhood
PDS Biotech jumps on early data for experimental colon cancer drug
U.S. STOCKS ON THE MOVE-Intel, Gartner, Chipotle
U.S. STOCKS ON THE MOVE-Spotify, Insmed, Nano Nuclear Energy
PDS Biotech rises as it seeks faster FDA nod for cancer drug
Brief: Pds Biotech Announces FDA Alignment On Use Of Progression Free Survival (Pfs) As Primary Endpoint